IBN (IBN) Stock Price & Analysis
IBN (IBN) rose 0.92% to USD 29.51 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
IBN last closed at USD 29.24; the session ranged USD 29.4–29.65 on volume of 2,579,285 shares. Market capitalization is —, with a 52-week range of USD 25.08–34.2 (NYQ). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 29.51 |
|---|---|
| Change | ▲ 0.92% (up) |
| Previous Close | USD 29.24 |
| Open | USD 29.39 |
| Day Range | USD 29.4 – 29.65 |
| 52-Week Range | USD 25.08 – 34.2 |
| Volume | 2,579,285 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (IBN)
Nexqual's technical model rates IBN "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 60.51 (neutral) |
| vs SMA50 | Above (USD 27.78) |
| MACD | 0.44 (positive) |
Analyst Ratings (IBN)
Wall Street analysts rate IBN "Strong Buy" based on 4 analysts, with a mean price target of USD 35.83 (range USD 35.3–36), per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 35.83 |
| High Target | USD 36 |
| Low Target | USD 35.3 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (IBN)
| Next Earnings Date | 2026-10-17 |
|---|---|
| EPS Estimate | USD 0.38 |
| Revenue Estimate | $338.90B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.42 vs est 0.41 ▲ beat |
| 2026-03-31 | USD 0.41 vs est 0.39 ▲ beat |
| 2025-12-31 | USD 0.34 vs est 0.38 ▼ miss |
| 2025-09-30 | USD 0.39 vs est 0.36 ▲ beat |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (IBN)
| Total Revenue | $2.04T |
|---|---|
| Revenue Growth (YoY) | +11.40% |
| Gross Margin | +0.00% |
| Operating Margin | +38.51% |
| Profit Margin | +27.53% |
| ROE | +16.07% |
| Total Cash | $1.96T |
| Total Debt | $2.26T |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (IBN)
Nexqual rates IBN's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Critical — Revenue -42% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Gross margin 0% |
| Balance Sheet | Mixed — $1.96T cash vs $2.26T debt |
| Cash Flow | Mixed — No data |
| Efficiency | Solid — ROE 16%, ROA 2.1% |
Ownership (IBN)
| Insider Ownership | +0.22% |
|---|---|
| Institutional Ownership | +17.60% |
| Float | 3.58B |
| Short % of Float | +1.57% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (IBN)
IBN is led by Sandeep Bakhshi B.E. (age 65), MD, CEO & Executive Director, per Nexqual as of July 25, 2026 at 02:21 UTC.
| MD, CEO & Executive Director | Sandeep Bakhshi B.E. (age 65) |
|---|---|
| Executive Director | Rakesh Jha BE, PGDM (age 53) |
| Executive Director | Sandeep Batra A.C.S., B.Com., CA, CS, F.C.A. (age 59) |
| Executive Director | Ajay Kumar Gupta B.Com, CA (age 58) |
| Group CFO & Head of Investor Relations | Anindya Banerjee (age 49) |
Major Backers & Investors (IBN)
Notable institutional backers of IBN include GQG Partners LLC, Morgan Stanley, WCM Investment Management, LLC, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| GQG Partners LLC | 2.16% |
| Morgan Stanley | 1.5% |
| WCM Investment Management, LLC | 1.46% |
| Goldman Sachs | 1.18% |
| Temasek Holdings (Private) Ltd | 0.81% |
| Invesco | 0.61% |
| Robeco Institutional Asset Management B.V. | 0.59% |
| FIL LTD | 0.39% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HDB | HDFC Bank Limited | USD 23.23 | ▲ 0.22% |
| WIT | Wipro Limited | USD 1.87 | ▲ 3.31% |
| RDY | Dr. Reddy's Laboratories Ltd | USD 11.79 | ▲ 3.6% |
| INFY | Infosys Limited | USD 11.11 | ▲ 1.65% |
| SAY | Saratoga Investment Corp 8.125% | USD 25.3 | ▲ 0.08% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.